Acorn Biolabs

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Acorn Biolabs sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 3 currently recruiting early-phase tilt upper quartile by trial count

Acorn Biolabs: 3 sponsored US clinical trials, 3 recruiting.

Acorn Biolabs sponsors 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Baldness, with 1 trials.

Upper-quartile sponsor footprint

Acorn Biolabs sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING Early Phase 1

Secretome Treatment for Facial Rejuvenation

NCT07227883
RECRUITING NA

Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)

NCT07107841
RECRUITING

Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures

NCT06477172

Phase Distribution

PhaseTrial count
Phase 1 1

Therapeutic Areas

Baldness 1
Androgenic Alopecia 1
Stem Cell Banking 1
Stem Cell 1
Rejuvenation 1
Facial Aging 1
Alopecia 1
Post Procedural Erythema 1

What is open in the Acorn Biolabs pipeline

3 recruiting of 3 indexed (100% open).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Baldness (1 trial), 7 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Acorn Biolabs: open-pipeline peers nationwide

Peers matched on 3 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Acorn Biolabs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%50%100%150% Total trials Recruiting share Acorn Biolabs10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAAVantgarde Bio SrlAcrivon TherapeuticsADARx PharmaceuticalsAdcendo ApS
Acorn Biolabs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Acorn Biolabs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Acorn Biolabs page

3 registered trials is a research-attention snapshot, not an endorsement of Acorn Biolabs or any single study.

  • 3 of Acorn Biolabs's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Baldness is the condition Acorn Biolabs studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Baldness trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Acorn Biolabs pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.